US7112592 — Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
Method of Use · Assigned to Aventis Pharma SA · Expires 2026-01-07 · 0y expired
What this patent protects
This patent protects new heterocyclic compounds and their salts, as well as a process for preparing them, for use as medicaments, particularly as antibacterial agents.
USPTO Abstract
The invention relates to new heterocyclic compounds of general formula (I), and their salts with a base or an acid: The invention also relates to a process for the preparation of these compounds as well as their use as medicaments, in particular as anti-bacterial agents.
Drugs covered by this patent
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-4147 |
— | |
U-2508 |
— |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.